S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
Top 10 Searched Stocks on MarketBeat All-Access
More, More, More ? Nuclear Energy, That Is... (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
3 Dividend Kings With Royally Good Upside
How High Can Copper Go? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Could trawler cams help save world's dwindling fish stocks?
How High Can Copper Go? (Ad)
Closing prices for crude oil, gold and other commodities
Why You Should Avoid Carvana Even if it Avoids Bankruptcy
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
Top 10 Searched Stocks on MarketBeat All-Access
More, More, More ? Nuclear Energy, That Is... (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
3 Dividend Kings With Royally Good Upside
How High Can Copper Go? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Could trawler cams help save world's dwindling fish stocks?
How High Can Copper Go? (Ad)
Closing prices for crude oil, gold and other commodities
Why You Should Avoid Carvana Even if it Avoids Bankruptcy
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
Top 10 Searched Stocks on MarketBeat All-Access
More, More, More ? Nuclear Energy, That Is... (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
3 Dividend Kings With Royally Good Upside
How High Can Copper Go? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Could trawler cams help save world's dwindling fish stocks?
How High Can Copper Go? (Ad)
Closing prices for crude oil, gold and other commodities
Why You Should Avoid Carvana Even if it Avoids Bankruptcy
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
Top 10 Searched Stocks on MarketBeat All-Access
More, More, More ? Nuclear Energy, That Is... (Ad)
Microsoft strikes 10-year deal with Nintendo on Call of Duty
3 Dividend Kings With Royally Good Upside
How High Can Copper Go? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Could trawler cams help save world's dwindling fish stocks?
How High Can Copper Go? (Ad)
Closing prices for crude oil, gold and other commodities
Why You Should Avoid Carvana Even if it Avoids Bankruptcy
NASDAQ:NVCN

Neovasc - NVCN Stock Forecast, Price & News

$8.24
-0.42 (-4.85%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$8.24
$8.83
50-Day Range
$6.50
$8.86
52-Week Range
$4.59
$17.50
Volume
6,293 shs
Average Volume
4,841 shs
Market Capitalization
$22.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NVCN stock logo

About Neovasc (NASDAQ:NVCN) Stock

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Receive NVCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter.

NVCN Stock News Headlines

Neovasc Announces Progress on COSIRA-II Clinical Trial
Neovasc Third Quarter 2022 Earnings: Misses Expectations
Form 6-K NEOVASC INC For: Sep 20 - StreetInsider.com
Neovasc Announces Key Events at TCT 2022 - GlobeNewswire
Neovasc Announces Key Events at TCT 2022
Neovasc: Q2 Earnings Snapshot - Greenwich Time
See More Headlines
Receive NVCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter.

NVCN Company Calendar

Last Earnings
11/09/2021
Today
12/08/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/09/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NVCN
Employees
49
Year Founded
N/A

Profitability

Net Income
$-24,890,000.00
Net Margins
-1,077.37%
Pretax Margin
-1,211.86%

Debt

Sales & Book Value

Annual Sales
$2.55 million
Book Value
$19.31 per share

Miscellaneous

Free Float
N/A
Market Cap
$22.58 million
Optionable
Not Optionable
Beta
2.11

Key Executives

  • Mr. Fredericus A. Colen (Age 70)
    Pres, CEO & Director
    Comp: $2.59M
  • Mr. Christopher Clark B.A. (Age 50)
    BA (Honours), C.A., CA, PgD, CFO & Corp. Sec.
    Comp: $1.07M
  • Mr. William Reed Little (Age 51)
    Chief Operating Officer
    Comp: $1.2M
  • Mr. John Christopher Panton (Age 55)
    Chief Quality Officer
    Comp: $380.98k
  • Sarah Marie-Hodgson Gallagher
    VP of Clinical Affairs













NVCN Stock - Frequently Asked Questions

Should I buy or sell Neovasc stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NVCN shares.
View NVCN analyst ratings
or view top-rated stocks.

How have NVCN shares performed in 2022?

Neovasc's stock was trading at $11.7150 on January 1st, 2022. Since then, NVCN shares have decreased by 29.7% and is now trading at $8.24.
View the best growth stocks for 2022 here
.

Are investors shorting Neovasc?

Neovasc saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 25,400 shares, an increase of 16.0% from the October 31st total of 21,900 shares. Based on an average daily volume of 6,300 shares, the days-to-cover ratio is currently 4.0 days. Approximately 1.0% of the company's stock are short sold.
View Neovasc's Short Interest
.

When is Neovasc's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 9th 2023.
View our NVCN earnings forecast
.

How were Neovasc's earnings last quarter?

Neovasc Inc. (NASDAQ:NVCN) posted its quarterly earnings results on Tuesday, November, 9th. The medical equipment provider reported ($2.75) earnings per share for the quarter, missing the consensus estimate of ($2.25) by $0.50. The medical equipment provider earned $0.70 million during the quarter, compared to analyst estimates of $1.20 million. Neovasc had a negative trailing twelve-month return on equity of 76.22% and a negative net margin of 1,077.37%. During the same period in the prior year, the firm earned ($12.75) earnings per share.

When did Neovasc's stock split?

Neovasc shares reverse split before market open on Friday, April 29th 2022. The 1-25 reverse split was announced on Friday, April 29th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What other stocks do shareholders of Neovasc own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neovasc investors own include Biopharmx (BPMX), Allstate (ALL), Amicus Therapeutics (FOLD), Synergy Pharmaceuticals (SGYP), Rexahn Pharmaceuticals (REXN), Heat Biologics (HTBX), Protalix BioTherapeutics (PLX), Palatin Technologies (PTN), Amarin (AMRN).

What is Neovasc's stock symbol?

Neovasc trades on the NASDAQ under the ticker symbol "NVCN."

How do I buy shares of Neovasc?

Shares of NVCN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Neovasc's stock price today?

One share of NVCN stock can currently be purchased for approximately $8.24.

How much money does Neovasc make?

Neovasc (NASDAQ:NVCN) has a market capitalization of $22.58 million and generates $2.55 million in revenue each year. The medical equipment provider earns $-24,890,000.00 in net income (profit) each year or ($12.29) on an earnings per share basis.

How can I contact Neovasc?

Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, RICHMOND A1, V6V 2J7. The official website for the company is www.neovasc.com. The medical equipment provider can be reached via phone at (604) 270-4344, via email at investors@neovasc.com, or via fax at 604-270-4384.

This page (NASDAQ:NVCN) was last updated on 12/8/2022 by MarketBeat.com Staff